Bayer | Pasivo Circulante



Current Liabilities Cambio Fecha
Air Liquide EUR 9.48B 883.8M 2024-12
Akzo Nobel EUR 4.73B 1.06B 2024-12
Alcon AG USD 2.28B 178M 2024-12
Amarin USD 201.55M 28.99M 2024-09
Arkema EUR 2.49B 49M 2024-12
AstraZeneca USD 27.87B 1.94B 2024-12
BASF EUR 16.99B 2.93B 2024-09
Bayer EUR 28.95B 3.9B 2024-12
Beiersdorf EUR 9.89B 5.62B 2024-12
Corteva USD 10.39B 38M 2024-12
Covestro EUR 3.63B 0 2024-09
Essilor EUR 10.56B 821M 2024-12
Fresenius EUR 6.09B 2.19B 2024-12
Fresenius Medical Care EUR 5.66B 228.94M 2024-12
Genmab DKK 5.31B 723M 2024-12
Givaudan CHF 2.97B 911M 2024-06
GlaxoSmithKline GBP 21.7B 238M 2024-12
GRIFOLS EUR 2.16B 199.43M 2024-12
Henkel EUR 8.78B 1.02B 2024-06
Hikma Pharmaceutical USD 1.38B 41M 2024-06
Johnson Matthey GBP 2.51B 12M 2024-09
Linde USD 14.54B 495M 2024-12
Lonza CHF 3.58B 970M 2024-12
Merck EUR 10.46B 532M 2024-09
Novartis USD 28.69B 560M 2024-12
Nutrien USD 12.04B 1.09B 2024-12
Philips EUR 8.15B 615M 2024-12
PPG Industries USD 5.01B 18M 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 30.03B 5.82B 2024-06
SAP EUR 19.08B 424M 2024-12
Solvay EUR 1.89B 163M 2024-12
UCB EUR 3.53B 731M 2024-12
Umicore EUR 4.35B 661.5M 2024-12
Vinci EUR 55.03B 749M 2024-12



Bayer Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.